Astrocyte RNA degradation and cognitive function
星形胶质细胞RNA降解和认知功能
基本信息
- 批准号:10705819
- 负责人:
- 金额:$ 56.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAdultAnimalsAstrocytesBehaviorBehavioralBehavioral AssayBioinformaticsBiological AssayBiological ProcessBrainBrain DiseasesCategoriesCell modelCellsCoculture TechniquesCognitionDendritesDetectionDiseaseElectrophysiology (science)EnsureEquilibriumExcisionExtracellular SpaceFunctional disorderGenesGeneticGlutamatesGoalsHigh-Throughput Nucleotide SequencingHippocampusImageImpaired cognitionImpairmentKnockout MiceKnowledgeLabelLearningLinkLiteratureLong-Term PotentiationMarbleMeasuresMediatingMemoryMemory impairmentMental disordersMessenger RNAModelingMolecularMusMutant Strains MiceNeurocognitiveNeurodevelopmental DisorderNeurogliaNeuronsOntologyPathway interactionsPhenotypeProcessProtein BiosynthesisPublishingRNARNA DegradationRegulationRegulatory PathwayReportingResearchResearch ProposalsRoleSignal TransductionSliceSynapsesSynaptic TransmissionSynaptic plasticityTamoxifenTechniquesTestingTimeTissuesTranscriptTranslatingViralWorkbehavior influencebehavioral impairmentbehavioral phenotypingcell typecognitive functioncognitive performancecrosslinking and immunoprecipitation sequencingdesignexperimental studyfunctional disabilityin vitro activityin vivoinsightmRNA DecaymRNA StabilitymRNA Transcript Degradationmorris water mazemouse modelmulti-electrode arraysnervous system disorderneurocognitive disorderneuropsychiatric disordernew therapeutic targetsynaptic functiontranscriptome sequencingtwo photon microscopytwo-photon
项目摘要
PROJECT SUMMARY
Despite its putative link to many mental illnesses, Nonsense-Mediated mRNA Decay (NMD) represents a
relatively unexplored mechanism for regulating mRNA stability in brain function. NMD functions in a tissue-,
cell type- and cell-state specific manner and modulates stability of selective mRNAs to fine-tune transcript
abundance. There is dearth of knowledge regarding the identity of such NMD target RNAs, particularly in cells
in their normal in vivo context. A particularly large gap in the field is the cell-specific function and targets
of NMD in vivo. Our recent work has established that neuronal NMD regulates GLUR1 signaling and is
required for proper synaptic plasticity, cognition, and local protein synthesis in dendrites, providing fundamental
insight into the neuron-specific function of NMD within the brain. To date, no study has reported a specific
function for NMD nor identified NMD substrates within glial cells in the brain. Astroglial control of synaptic
activity translates into regulation of cognition making astrocytes a novel therapeutic target to treat cognitive
dysfunctions. However, the mechanisms through which astrocytes regulate neuronal function are not well
understood. Currently, it is not known whether mRNA degradation in astrocytes contribute to the regulation of
synaptic plasticity and behavior. The goal of this application is to determine the contribution of astrocytic
NMD to synaptic plasticity and cognitive performance. Several predicted ‘canonical’ and ‘atypical’ NMD
targets are expressed in astrocytes. Our gene ontology analysis of these predicted NMD targets identified
molecular function enrichment for Ca2+ signaling. Consistent with this, we have found that disruption of NMD in
astrocytes resulted in elevated Ca2+ activity in vitro. Dynamic Ca2+ transients in astrocytes have been
suggested to control proper basal synaptic transmission and modulate hippocampal LTP. We have also found
that conditional ablation of NMD in astrocytes impaired memory in the adult mice. Based on the published
literature and our preliminary studies, we hypothesize that NMD regulates Ca2+ activity in astrocytes, and
astrocytic NMD is required for proper cognitive function and behavior in the adult brain. To test this
hypothesis, we propose to determine 1) whether NMD is required for different aspects of learning and memory
2) the effects of astrocytic NMD ablation on neurons (e.g., assessing neuronal network connectivity and
synaptic plasticity) and 3) functional deficits of NMD-deficient astrocytes (i.e., by assessing Ca2+ activity in vivo)
and in vivo NMD targets in astrocytes. We will use a combination of techniques including an inducible-genetic
mouse model, behavioral assays, electrophysiology, live-animal Ca2+ imaging by two-photon microscopy,
stereotaxic viral labeling, Multielectrode Array Assay, in vivo RNAseq/bioinformatics, and in vivo HITS-CLIP.
The successful completion of this research will provide a coherent view of how cell-specific mRNA degradation
underlies the highly regulated synaptic and cognitive function in the mammalian brain and might be valuable
for providing new insights into the astrocytic mechanisms of synaptic dysfunction and neurocognitive diseases.
PROJECT SUMMARY
Despite its putative link to many mental illnesses, Nonsense-Mediated mRNA Decay (NMD) represents a
relatively unexplored mechanism for regulating mRNA stability in brain function. NMD functions in a tissue-,
cell type- and cell-state specific manner and modulates stability of selective mRNAs to fine-tune transcript
abundance. There is dearth of knowledge regarding the identity of such NMD target RNAs, particularly in cells
in their normal in vivo context. A particularly large gap in the field is the cell-specific function and targets
of NMD in vivo. Our recent work has established that neuronal NMD regulates GLUR1 signaling and is
required for proper synaptic plasticity, cognition, and local protein synthesis in dendrites, providing fundamental
insight into the neuron-specific function of NMD within the brain. To date, no study has reported a specific
function for NMD nor identified NMD substrates within glial cells in the brain. Astroglial control of synaptic
activity translates into regulation of cognition making astrocytes a novel therapeutic target to treat cognitive
dysfunctions. However, the mechanisms through which astrocytes regulate neuronal function are not well
understood. Currently, it is not known whether mRNA degradation in astrocytes contribute to the regulation of
synaptic plasticity and behavior. The goal of this application is to determine the contribution of astrocytic
NMD to synaptic plasticity and cognitive performance. Several predicted ‘canonical’ and ‘atypical’ NMD
targets are expressed in astrocytes. Our gene ontology analysis of these predicted NMD targets identified
molecular function enrichment for Ca2+ signaling. Consistent with this, we have found that disruption of NMD in
astrocytes resulted in elevated Ca2+ activity in vitro. Dynamic Ca2+ transients in astrocytes have been
suggested to control proper basal synaptic transmission and modulate hippocampal LTP. We have also found
that conditional ablation of NMD in astrocytes impaired memory in the adult mice. Based on the published
literature and our preliminary studies, we hypothesize that NMD regulates Ca2+ activity in astrocytes, and
astrocytic NMD is required for proper cognitive function and behavior in the adult brain. To test this
hypothesis, we propose to determine 1) whether NMD is required for different aspects of learning and memory
2) the effects of astrocytic NMD ablation on neurons (e.g., assessing neuronal network connectivity and
synaptic plasticity) and 3) functional deficits of NMD-deficient astrocytes (i.e., by assessing Ca2+ activity in vivo)
and in vivo NMD targets in astrocytes. We will use a combination of techniques including an inducible-genetic
mouse model, behavioral assays, electrophysiology, live-animal Ca2+ imaging by two-photon microscopy,
stereotaxic viral labeling, Multielectrode Array Assay, in vivo RNAseq/bioinformatics, and in vivo HITS-CLIP.
The successful completion of this research will provide a coherent view of how cell-specific mRNA degradation
underlies the highly regulated synaptic and cognitive function in the mammalian brain and might be valuable
for providing new insights into the astrocytic mechanisms of synaptic dysfunction and neurocognitive diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dilek Colak其他文献
Dilek Colak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dilek Colak', 18)}}的其他基金
Exploring exosomes in neurodevelopmental and neuropsychiatric diseases using brain organoids
使用脑类器官探索外泌体在神经发育和神经精神疾病中的作用
- 批准号:
10741385 - 财政年份:2023
- 资助金额:
$ 56.6万 - 项目类别:
Astrocyte RNA degradation and cognitive function
星形胶质细胞RNA降解和认知功能
- 批准号:
10585257 - 财政年份:2022
- 资助金额:
$ 56.6万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
9541044 - 财政年份:2018
- 资助金额:
$ 56.6万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
10307110 - 财政年份:2018
- 资助金额:
$ 56.6万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
10055968 - 财政年份:2018
- 资助金额:
$ 56.6万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 56.6万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 56.6万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 56.6万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 56.6万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 56.6万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 56.6万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 56.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 56.6万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 56.6万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 56.6万 - 项目类别: